Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 15265788

Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2004 Nov 15
First author
Palumbo A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Palumbo A
      type
      Author
    2. name
      Bringhen S
      type
      Author
    3. name
      Petrucci MT
      type
      Author
    4. name
      Musto P
      type
      Author
    5. name
      Rossini F
      type
      Author
    6. name
      Nunzi M
      type
      Author
    7. name
      Lauta VM
      type
      Author
    8. name
      Bergonzi C
      type
      Author
    9. name
      Barbui A
      type
      Author
    10. name
      Caravita T
      type
      Author
    11. name
      Capaldi A
      type
      Author
    12. name
      Pregno P
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Palumbo A
      type
      Author
    2. name
      Bringhen S
      type
      Author
    3. name
      Petrucci MT
      type
      Author
    4. name
      Musto P
      type
      Author
    5. name
      Rossini F
      type
      Author
    6. name
      Nunzi M
      type
      Author
    7. name
      Lauta VM
      type
      Author
    8. name
      Bergonzi C
      type
      Author
    9. name
      Barbui A
      type
      Author
    10. name
      Caravita T
      type
      Author
    11. name
      Capaldi A
      type
      Author
    12. name
      Pregno P
      type
      Author
    bibliography ids
    1. nci-bib-199327d0636b12000dab790a
    book metadata
    content sha256
    05db439b7e68d8e2122573b694a8eb1efb0666dc50f52fb886a513ef7ad79d06
    document type
    citation
    dois
    1. 10.1182/blood-2004-02-0408
    electronic publication date
    display
    2004 Jul 20
    precision
    day
    year
    2004
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:15265788
    immutable id
    pubmed:15265788@05db439b7e68d8e2122573b694a8eb1efb0666dc50f52fb886a513ef7ad79d06
    journal
    abbreviation
    Blood
    issn electronic
    Source null
    issn print
    0006-4971
    issue
    10
    name
    Blood
    nlm unique id
    7603509
    pages
    3052-7
    volume
    104
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      15265788
      provenance
      batch id
      748437a772c9631ad901
      provider
      NCBI PubMed ESummary
      record sha256
      20dd29e0758868c51c14150f959f0de63725707b72ab5e874af7da02beb8e5a9
      response sha256
      1535c16de1ca2ef53b01ccf9e7709049035aa1b159955f06fbec3d1a0daddc80
      retrieved at
      2026-09-09T23:45:55.399079+00:00
      publication date
      display
      2004 Nov 15
      precision
      day
      year
      2004
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Randomized Controlled Trial
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/15265788/
      title
      Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial.

      Preserved source evidence · Not medical advice